Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-kappaB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia[2].
Molecular Weight:
234.34
Purity:
99.96
CAS Number:
[137-58-6]
Formula:
C14H22N2O
Target:
Apoptosis,ERK,MEK,NF-kappaB,Sodium Channel
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
